HCP (NYSE:HCP) announced that it intends to issue 11,500,000 shares of
its common stock. Net proceeds from the offering will be used to repay
all borrowings under HCP’s revolving credit facility, including
borrowings that were applied toward the cash payment of $165 million for
the participation in first mortgage debt of HCR ManorCare, with the
remainder to be used for general corporate purposes. The shares are
being offered pursuant to an effective registration statement filed with
the Securities and Exchange Commission. BofA Merrill Lynch will act as
book-running manager for the offering.
The offering of shares of HCP common stock may be made only by means of
a prospectus. A copy of the prospectus relating to the offering will be
filed with the Securities and Exchange Commission and, when available,
can be obtained from BofA Merrill Lynch, Attn: Prospectus Department, 4
World Financial Center, New York, New York 10080, or by telephone at
(212) 449-1000.
This communication shall not constitute an offer to sell or the
solicitation of an offer to buy, nor shall there be any sale of these
securities in any state or jurisdiction in which such offer,
solicitation or sale would be unlawful prior to registration or
qualification under the securities laws of any such state or
jurisdiction.
About HCP
HCP, Inc., an S&P 500 company, is a real estate investment trust (REIT)
that, together with its consolidated subsidiaries, invests primarily in
real estate serving the healthcare industry in the United States. As of
June 30, 2009, HCP’s portfolio of properties, excluding assets held for
sale but including properties owned by unconsolidated joint ventures,
totaled 682 properties among the following segments: 259 senior housing,
100 life science, 253 medical office, 22 hospital and 48 skilled nursing.
Forward-looking Statements
The statements contained in this release which are not historical facts
are forward-looking statements within the meaning of Section 27A of the
Securities Act of 1933 and Section 21E of the Securities Exchange Act of
1934. These statements are subject to risks and uncertainties that could
cause actual results to differ materially from those set forth in or
implied by forward-looking statements. These risks and uncertainties
include general economic conditions and the ability of HCP to complete
the offering and receive the resulting proceeds. Some of these risks,
and other risks, are described from time to time in HCP’s Securities and
Exchange Commission filings.
HCP
Thomas M. Herzog
Executive Vice President — Chief
Financial Officer and Treasurer
562-733-5309
